申请人:Eccogene (Shanghai) Co., Ltd.
公开号:US20210147360A1
公开(公告)日:2021-05-20
The application relates to a compound of Formula (I′) or (I):
or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of SSAO, a pharmaceutical composition comprising a compound of Formula (I′) or (I), and a method of treating or preventing a disease in which SSAO plays a role.